NEUROCHEMICAL PARAMETERS IN THE HYPER-RESPONSIVE PHASE AFTER A SINGLE DOSE OF NEUROLEPTICS TO MICE

被引:12
作者
HYTTEL, J
机构
[1] Department of Pharmacology and Toxicology, H Lundbeck & Co, Copenhagen, 2500
关键词
D O I
10.1111/j.1471-4159.1979.tb05208.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abstract— Four days after a single dose of teflutixol (5 mg/kg i.p.), at which time mice are superresponsive to dopamine agonists, e.g. apomorphine, the specific binding of [3H]haloperidol, [3H]cis (Z)‐flupenthixol, [3H]apomorphine, [3H]dopamine, [3H]propylbenzilylcholine mustard and [3H]GABA to striatal membranes in vitro is equal to that of saline‐treated mice. Specific binding of [3H]haloperidol is also unchanged 3 days following a single dose of fluphenazine (5mg/kg i.p.) and 2 days following haloperidol (5 mg/kg i.p.), but slightly decreased 3 days following cis(Z)‐flupenthixol (5 mg/kg i.p.). The possibility that remaining neuroleptic or active metabolites could obscure a slight increase in dopamine receptor binding was rejected, since remaining amounts of [3H]teflutixol in the final binding assay 4 days after intraperitoneal injection of [3H]teflutixol (5 mg/kg) were too small to influence the binding of [3H]haloperidol in vitro. It is concluded that the pharmacological superresponsiveness and the decrease in dopamine synthesis and release seen after the initial receptor blockade following a single dose of neuroleptic drugs in mice are nor accompanied by changes in dopamine, muscarine or GABAergic receptor characteristics in corpus striatum. The possibility that changes occur in a small number of functional operative dopamine receptors cannot be excluded, however. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:641 / 646
页数:6
相关论文
共 24 条
[1]  
BURT DR, 1976, MOL PHARMACOL, V12, P800
[2]   ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN [J].
BURT, DR ;
CREESE, I ;
SNYDER, SH .
SCIENCE, 1977, 196 (4287) :327-328
[3]  
CHRISTENSEN A V, 1973, Acta Physiologica Scandinavica Supplementum, V396, P78
[4]   SUPERSENSITIVITY OF DOPAMINE RECEPTORS, INDUCED BY NEUROLEPTICS [J].
CHRISTENSEN, AV ;
FJALLAND, B ;
NIELSEN, IM .
PSYCHOPHARMACOLOGY, 1976, 48 (01) :1-6
[5]  
CHRISTENSEN AV, 1979, PSYCHOPHARMACOLOGY, V62, P111, DOI 10.1007/BF00427122
[6]   DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J].
CREESE, I ;
BURT, DR ;
SNYDER, SH .
LIFE SCIENCES, 1975, 17 (06) :993-1001
[7]  
ENNA SJ, 1977, MOL PHARMACOL, V13, P442
[8]  
FJALLAND B, 1977, ARCH EXP PATHOL PH, V301, P5
[9]  
FRIEDHOFF AJ, 1977, RES COMMUN CHEM PATH, V16, P411